Westfield Capital Management CO LP Ascendis Pharma A/S Transaction History
Westfield Capital Management CO LP
- $21.9 Billion
- Q3 2025
A detailed history of Westfield Capital Management CO LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Westfield Capital Management CO LP holds 5,259,909 shares of ASND stock, worth $1.08 Billion. This represents 4.77% of its overall portfolio holdings.
Number of Shares
5,259,909
Previous 5,479,259
4.0%
Holding current value
$1.08 Billion
Previous $854 Million
22.45%
% of portfolio
4.77%
Previous 4.42%
Shares
29 transactions
Others Institutions Holding ASND
# of Institutions
318Shares Held
65MCall Options Held
476KPut Options Held
142K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.1 Billion35.1% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.11MShares$1.04 Billion13.88% of portfolio
-
Janus Henderson Group PLC London, X04.32MShares$884 Million0.41% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X04.27MShares$873 Million0.89% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$761 Million1.13% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.4B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...